Related Experiment Videos
In vitro activity of flomoxef in comparison to other cephalosporins
Abstract:
Flomoxef and cefazolin had nearly the same activity against staphylococci, which was stronger than that of other cephalosporins. Against Streptococcus pyogenes, Streptococcus agalactiae and Streptococcus pneumoniae, cefotaxime and cefazolin were more active than flomoxef, but the other cephamycins were less active than flomoxef. In comparison to the other cephalosporins, latamoxef and flomoxef had higher activity against Branhamella catarrhalis, whereas cefotaxime, latamoxef and cefotetan were more active against Haemophilus influenzae. Flomoxef was the only drug exhibiting activity against Clostridium difficile. The activity of flomoxef and latamoxef against Bacteroides fragilis was stronger than that of the other cephalosporins, but Bacteroides bivius was resistant to each of these antibiotics.
Insights
Flomoxef demonstrates broad-spectrum antibacterial activity, particularly against staphylococci and Clostridium difficile. Its efficacy varies across different bacterial species compared to other cephalosporins.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Cephalosporins are a class of beta-lactam antibiotics widely used to treat bacterial infections.
- Understanding the comparative activity of different cephalosporins against key pathogens is crucial for effective antimicrobial therapy.
Purpose of the Study:
- To evaluate and compare the in vitro antibacterial activity of flomoxef against a range of clinically relevant bacteria.
- To assess the activity of flomoxef relative to other cephalosporins, including cefazolin, cefotaxime, latamoxef, and cefotetan.
Main Methods:
- In vitro susceptibility testing was performed.
- Comparative analysis of the activity of flomoxef and other cephalosporins against various bacterial strains, including Staphylococcus, Streptococcus, Branhamella catarrhalis, Haemophilus influenzae, Clostridium difficile, and Bacteroides species.
Main Results:
- Flomoxef exhibited potent activity against staphylococci, comparable to cefazolin and superior to other cephalosporins.
- Flomoxef showed significant activity against Clostridium difficile, a characteristic not observed with other tested cephalosporins.
- Comparative analysis revealed varying degrees of activity for flomoxef and other cephalosporins against Streptococcus species, Branhamella catarrhalis, Haemophilus influenzae, and Bacteroides fragilis.
Conclusions:
- Flomoxef possesses a broad spectrum of activity, with notable efficacy against staphylococci and Clostridium difficile.
- Flomoxef represents a valuable therapeutic option, demonstrating distinct advantages over certain other cephalosporins in specific clinical scenarios.